The global exosomes market size reached USD 0.50 Billion in 2021 and is expected to register a revenue CAGR of 18% during the forecast period, according to latest analysis by Emergen Research.
The global exosomes market size reached USD 0.50 Billion in 2021 and is expected to register a revenue CAGR of 18% during the forecast period, according to latest analysis by Emergen Research. The increasing application of exosomes in therapeutics is one of the major factors expected to drive market growth during the forecast period. Exosomes have gained significant traction as a potential therapeutic agent for various diseases, such as cancer, neurological disorders, and cardiovascular diseases, among others. Moreover, the rising awareness about the potential applications of exosomes and the increasing investment by key market players to develop new exosome-based therapeutics are some of the other factors expected to drive market growth during the forecast period.
However, the lack of standardization in manufacturing process and regulatory hurdles associated with the approval of exosome-based therapeutics are some of the major factors expected to restraint market growth during the forecast period.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1044
Exosomes can be defined as nanovesicles that are released from various cells, such as macrophages, dendritic cells, and cancer cells. These vesicles are spherical in shape and range in size from 30 nm to 100 nm. Exosomes are composed of a lipid bilayer that encloses various proteins, lipids, mRNA, and other biomolecules. These vesicles play an important role in cell-to-cell communication by transferring their contents to other cells. Exosomes are involved in various biological processes, such as antigen presentation, cell proliferation, and cell death.
Exosomes are being increasingly used as a therapeutic agent for various diseases, such as cancer, neurological disorders, and cardiovascular diseases. Moreover, the rising investment by key market players to develop new exosome-based therapeutics is expected to drive market growth during the forecast period.
Some Key Highlights From the Report
- The B2B segment registered the largest revenue share of 41.8% in 2020 and is expected to register the highest CAGR of 19.6% during the forecast period. The increasing demand for exosomes for research purposes is one of the major factors driving the growth of this segment during the forecast period.
- The therapeutics segment is expected to register the highest CAGR of 18.8% during the forecast period. Exosomes are being increasingly used as a therapeutic agent for various diseases, such as cancer, neurological disorders, and cardiovascular diseases. Moreover, the rising investment by key market players to develop new exosome-based therapeutics is expected to drive the growth of this segment during the forecast period.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/exosomes-market
- The cancer segment is expected to register the highest CAGR of 19.2% during the forecast period. Exosomes are being increasingly used as a therapeutic agent for cancer due to their ability to deliver drugs and other therapeutic agents to cancer cells.
- North America held the largest revenue share of 39.3% in 2020 and is expected to register the highest CAGR of 18.5% during the forecast period. The presence of key market players, such as Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., and Danaher Corporation, in this region is one of the major factors driving the growth of the market in North America. Moreover, the increasing investment by government and private organizations to develop new exosome-based therapeutics is expected to drive the growth of the market in this region during the forecast period.
- The Europe exosomes market is expected to grow at a relatively high rate during the forecast period. This is attributed to the rising prevalence of chronic diseases, such as cancer and neurological disorders, in the region. Moreover, increasing awareness about the potential therapeutic applications of exosomes is expected to fuel market growth in the region.
- The Asia Pacific exosomes market is expected to grow at a rapid pace during the forecast period, owing to the increasing prevalence of chronic diseases, such as cancer and neurological disorders, in the region. Moreover, increasing awareness about the potential therapeutic applications of exosomes is expected to drive market growth in the region.
- Some major companies in the global market report include QIAGEN, Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Codiak Biosciences, Exosome Diagnostics, Evox Therapeutics, ExCoBio Inc., Bio-Rad Laboratories Ltd., and Beckman Coulter, Inc.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1044
Emergen Research has segmented global exosomes market on the basis of type, product type, application, and region:
- Type Outlook (Revenue, USD Billion; 2019-2030)
- Biomarkers
- Drug Delivery Systems
- Vaccine Development
- Therapeutic Agents
- Others
- Product Type Outlook (Revenue, USD Billion; 2019-2030)
- Kits
- Reagents
- Instruments
- Application Outlook (Revenue, USD Billion; 2019-2030)
- Cancer
- Neurodegenerative Disease
- Cardiovascular Diseases
- Infectious Diseases
- Tissue Regeneration
- Others
- Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1044
Read Latest Articles Published by Emergen Research:
Plant-Based Food & Beverage Alternatives Market
Fermented Food and Ingredients Market
Autonomous Delivery Vehicles Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-exosomes-market